THE LONCAR CANCER IMMUNOTHERAPY INDEX (CURRENT COMPONENTS)

  1. Inovio (INO)
  2. Five Prime Therapeutics (FPRX)
  3. Merck (MRK)
  4. Agenus (AGEN)
  5. Xencor (XNCR)
  6. Cellectis (CLLS)
  7. Pfizer (PFE)
  8. Amgen (AMGN)
  9. Adaptimmune Therapeutics (ADAP)
  10. Bristol Myers-Squibb (BMY)
  11. Celgene (CELG)
  12. Celyad (CYAD)
  13. Novartis (NVS)
  14. Advaxis (ADXS)
  15. AstraZeneca (AZN)
  16. Juno Therapeutics (JUNO)
  17. ZIOPHARM Oncology (ZIOP)
  18. bluebird bio (BLUE)
  19. Kite Pharma (KITE)
  20. Immune Design (IMDZ)
  21. Incyte Corporation (INCY)
  22. CytomX Therapeutics (CTMX)
  23. Lion Biotechnologies (LBIO)
  24. Macrogenics, Inc. (MGNX)
  25. Atara Biotherapeutics (ATRA)
  26. NantKwest (NK)
  27. Bellicum Pharmaceuticals (BLCM)
  28. NewLink Genetics (NLNK)
  29. Aduro BioTech (ADRO)
  30. Celldex Therapeutics (CLDX)